Keeler Thomas Management LLC lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 37.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,129 shares of the semiconductor company’s stock after buying an additional 1,392 shares during the quarter. Synopsys comprises 1.0% of Keeler Thomas Management LLC’s investment portfolio, making the stock its 25th biggest position. Keeler Thomas Management LLC’s holdings in Synopsys were worth $2,531,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Atlantic Union Bankshares Corp boosted its stake in shares of Synopsys by 24.5% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 548 shares of the semiconductor company’s stock valued at $270,000 after purchasing an additional 108 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Synopsys by 69.4% in the 3rd quarter. Jones Financial Companies Lllp now owns 7,716 shares of the semiconductor company’s stock worth $3,766,000 after buying an additional 3,162 shares during the period. Howard Bailey Securities LLC bought a new position in shares of Synopsys during the 3rd quarter worth approximately $232,000. A4 Wealth Advisors LLC purchased a new position in shares of Synopsys in the 3rd quarter valued at approximately $263,000. Finally, Atlatl Advisers LLC purchased a new position in Synopsys during the 3rd quarter worth approximately $310,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,157 shares of company stock valued at $1,945,036 over the last ninety days. Corporate insiders own 0.62% of the company’s stock.
Synopsys Trading Down 1.6%
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the firm posted $3.40 EPS. The business’s quarterly revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Analyst Upgrades and Downgrades
SNPS has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Needham & Company LLC increased their price objective on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Citigroup began coverage on shares of Synopsys in a research note on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Wells Fargo & Company increased their price objective on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a report on Thursday, December 11th. Finally, KeyCorp lifted their price objective on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and a consensus target price of $553.57.
View Our Latest Stock Report on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
